Viewing Study NCT00185692



Ignite Creation Date: 2024-05-05 @ 11:56 AM
Last Modification Date: 2024-10-26 @ 9:17 AM
Study NCT ID: NCT00185692
Status: COMPLETED
Last Update Posted: 2019-12-04
First Post: 2005-09-12

Brief Title: Allogeneic Transplantation From Related Haploidentical Donors
Sponsor: Stanford University
Organization: Stanford University

Study Overview

Official Title: Allogeneic Hematopoietic Cell Transplantation of Positively Selected CD34 Cells and Defined Inoculum of T Cells From Related Haploidentical Donors for Older Patients With Indolent Hematologic Malignancies
Status: COMPLETED
Status Verified Date: 2015-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of the study is to evaluate the feasibility and safety of transplanting CD34 selected hematopoietic cells from a haploidentical related donor following a nonmyeloablative regimen of total lymphoid irradiation TLI and antithymocyte globulin ATG
Detailed Description: An alternative to conventional allogeneic bone marrow transplantation is by using a non-myeloablative conditioning regimen This regime would consist of both total lymphoid irradiation TLI and anti-thymocyte globulin ATG Used in combination to achieve engraftment of haploidentical CD34 selected peripheral blood stem cells in older patients or patients with underlying medical conditions that preclude standard allogeneic treatment The expected results of this transplant regime will be expected to result in hematopoietic and immunologic reconstitution decreased deaths related to the treatment regimen and decreased gravft-vs-host disease GVHD

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
BMT124 OTHER OnCore None
75117 OTHER None None